Article

Differential Expression of Immunohistochemical Markers in Ameloblastoma & Ameloblastic Carcinoma: A Systematic Review and Meta-analysis of observational studies

2024-05-31

Abstract excerpt

<h4>Background: </h4> Differentiating between ameloblastoma (AB) and ameloblastic carcinoma (AC) is difficult, especially when AB has atypical cytological characteristics or an uncommon clinical history. This systematic review and meta-analysis aimed to elucidate the differential expression of immunohistochemical markers between AB and AC. Methods We conducted a thorough search of PUBMED and SCOPUS according to th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1fc6b53f-995c-5017-b389-62f18123c3f1
DOI: 10.12688/f1000research.149861.1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Differential Expression of Immunohistochemical Markers in Ameloblastoma & Ameloblastic Carcinoma: A Systematic Review and Meta-analysis of observational studiesDOI 10.12688/f1000research.149861.1Read

Molecular biology exploration and targeted therapy strategy of Ameloblastoma.Semantic proximity Read

Cystic Plexiform Ameloblastoma – an important diagnostic challengeSemantic proximity Read

Diagnostic accuracy of immunohistochemistry compared with molecular tests for detection of BRAF V600E mutation in ameloblastomas: Systematic review and meta-analysis.Semantic proximity Read

A novel marker of ameloblastoma and systematic review of immunohistochemical findings.Semantic proximity Read

Genes and Genetic Pathways Regarding the Etiology and Pathogenesis of Ameloblastoma.Semantic proximity Read

Prevalence and Epidemiological Profile of Ameloblastoma in India: A Systematic Review and Meta-Analyses.Semantic proximity Read

Effectiveness of molecular-targeted chemotherapy in ameloblastomas: A systematic review.Semantic proximity Read

Genomic analyses identify significant molecules and signaling pathways in ameloblastomaSemantic proximity Read

Ameloblastoma: A succinct review of the classification, genetic understanding and novel molecular targeted therapies.Semantic proximity Read

Identification of key biomarkers related to epithelial‐mesenchymal transition and immune infiltration in ameloblastoma using integrated bioinformatics analysisSemantic proximity Read

Factors affecting the accuracy of anti-BRAF V600E immunohistochemistry results in ameloblastomas.Semantic proximity Read

Adenoid 'ameloblastoma': Clinicopathological description of 4 additional BRAF-negative cases.Semantic proximity Read